Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
RBM7 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
HNF4G - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
F2RL1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
B2M - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SSC5D - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CREBRF - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TGFA - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GATA6 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PIK3R1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
C3orf38 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GABARAPL1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
DCP1A - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CD83 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ZCCHC2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
HLA-G - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
NUB1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
VEZF1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CTSO - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CLEC7A - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PATL1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on